ArticleBMC microbiology2026
Whole-genome sequencing and in vitro characterization of two lactic acid bacteria isolates with potent antimicrobial activity from fermented vegetables.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Lactic acid bacteria (LAB) exist in various sources including the gastrointestinal tract and fermented foods, and are considered beneficial for animal and human health. In this study, two LAB strains Lactiplantibacillus plantarum CLPX16 and Weissella cibaria CLPX19 were isolated from fermented vegetables and characterized for probiotic properties through whole-genome sequencing and in vitro functional assays. Genomic analysis revealed that although homologs of several virulence-related genes were detected in both strains, they exhibited low sequence identities and lacked classical virulence gene determinants such as toxins, secretion systems, or invasion proteins. In contrast, both strains harbored beneficial genes including bacteriocin biosynthesis clusters and secondary metabolite gene clusters associated with antimicrobial and antioxidant properties. Both strains exhibited strong tolerance to acidic conditions with high survival rates at pH 2.0, 3.0, and 4.0, as well as tolerance to bile salts. Moreover, both strains exhibited robust acid production capacity, inducing a rapid pH decline during 0-36 h of incubation. In addition, both strains exhibited notable antioxidative activity, nitrite degradation capacity, and adhesion capacity. Importantly, CLPX16 and CLPX19 exhibited potent antimicrobial activity against foodborne pathogens including Staphylococcus aureus, Escherichia coli, and Salmonella enterica. Notably, these strains lacked hemolytic activity and showed low risk of horizontal transfer of antibiotic resistance genes. In conclusion, CLPX16 and CLPX19 demonstrate promising probiotic potential and represent candidate strains for application in food and health industries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.